Literature DB >> 25362199

Spontaneous regression of colon cancer.

Kyoichi Kihara1, Shin Fujita2, Taihei Ohshiro3, Seiichiro Yamamoto4, Shigeki Sekine5.   

Abstract

A case of spontaneous regression of transverse colon cancer is reported. A 64-year-old man was diagnosed as having cancer of the transverse colon at a local hospital. Initial and second colonoscopy examinations revealed a typical cancer of the transverse colon, which was diagnosed as moderately differentiated adenocarcinoma. The patient underwent right hemicolectomy 6 weeks after the initial colonoscopy. The resected specimen showed only a scar at the tumor site, and no cancerous tissue was proven histologically. The patient is alive with no evidence of recurrence 1 year after surgery. Although an antitumor immune response is the most likely explanation, the exact nature of the phenomenon was unclear. We describe this rare case and review the literature pertaining to spontaneous regression of colorectal cancer.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  colon cancer; immune response; spontaneous regression

Mesh:

Year:  2014        PMID: 25362199     DOI: 10.1093/jjco/hyu170

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Spontaneous regression of transverse colon cancer: a case report.

Authors:  Keigo Chida; Kazuaki Nakanishi; Hiroki Shomura; Shigenori Homma; Atsuo Hattori; Keizo Kazui; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2017-05-10

2.  A mathematical solution to Peto's paradox using Polya's urn model: implications for the aetiology of cancer in general.

Authors:  Anastasio Salazar-Bañuelos
Journal:  Theory Biosci       Date:  2019-02-15       Impact factor: 1.919

3.  A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.

Authors:  Chen Jianxin; Xu Qingxia; Wang Junhui; Zheng Qinhong
Journal:  Integr Cancer Ther       Date:  2016-07-21       Impact factor: 3.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.